Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2

This case report demonstrates an excellent outcome in a child with acute necrotizing encephalitis that was likely associated with the post-infectious SARS-CoV-2. The aim of this report is to emphasize that early diagnosis and initiation of immunotherapy treatment may yield good outcome, particularly...

Full description

Bibliographic Details
Published in:CUREUS JOURNAL OF MEDICAL SCIENCE
Main Authors: Azmi, Anayasmin; Abidin, Anis Siham Zainal
Format: Article
Language:English
Published: SPRINGERNATURE 2023
Subjects:
Online Access:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001168593900020
author Azmi
Anayasmin; Abidin
Anis Siham Zainal
spellingShingle Azmi
Anayasmin; Abidin
Anis Siham Zainal
Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
General & Internal Medicine
author_facet Azmi
Anayasmin; Abidin
Anis Siham Zainal
author_sort Azmi
spelling Azmi, Anayasmin; Abidin, Anis Siham Zainal
Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
CUREUS JOURNAL OF MEDICAL SCIENCE
English
Article
This case report demonstrates an excellent outcome in a child with acute necrotizing encephalitis that was likely associated with the post-infectious SARS-CoV-2. The aim of this report is to emphasize that early diagnosis and initiation of immunotherapy treatment may yield good outcome, particularly with the use of tocilizumab and high-dose methylprednisolone. Post immunotherapy, significant neurological improvement was seen through the gradual improvement of Glasgow Coma Scale (GCS) score of 6 to GCS score of 12 within three weeks and subsequently acquired almost full neurological function with minimally dependent activity of daily living (ADL) at eight weeks in the post-treatment follow-up. It is interesting to identify that the possible causative factor could be the natural infection in a vaccinated patient. This was evidenced by the persistently high SARS-CoV-2 immunoglobulin G (IgG)-Spike antibodies titre in a patient vaccinated with two doses of BNT162b2, 11 months before presentation.
SPRINGERNATURE

2168-8184
2023
15
8
10.7759/cureus.43198
General & Internal Medicine
Green Published, gold
WOS:001168593900020
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001168593900020
title Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
title_short Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
title_full Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
title_fullStr Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
title_full_unstemmed Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
title_sort Good Outcome With Respect to Acute Necrotizing Encephalitis in Children Associated With Post-infectious SARS-CoV-2
container_title CUREUS JOURNAL OF MEDICAL SCIENCE
language English
format Article
description This case report demonstrates an excellent outcome in a child with acute necrotizing encephalitis that was likely associated with the post-infectious SARS-CoV-2. The aim of this report is to emphasize that early diagnosis and initiation of immunotherapy treatment may yield good outcome, particularly with the use of tocilizumab and high-dose methylprednisolone. Post immunotherapy, significant neurological improvement was seen through the gradual improvement of Glasgow Coma Scale (GCS) score of 6 to GCS score of 12 within three weeks and subsequently acquired almost full neurological function with minimally dependent activity of daily living (ADL) at eight weeks in the post-treatment follow-up. It is interesting to identify that the possible causative factor could be the natural infection in a vaccinated patient. This was evidenced by the persistently high SARS-CoV-2 immunoglobulin G (IgG)-Spike antibodies titre in a patient vaccinated with two doses of BNT162b2, 11 months before presentation.
publisher SPRINGERNATURE
issn
2168-8184
publishDate 2023
container_volume 15
container_issue 8
doi_str_mv 10.7759/cureus.43198
topic General & Internal Medicine
topic_facet General & Internal Medicine
accesstype Green Published, gold
id WOS:001168593900020
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001168593900020
record_format wos
collection Web of Science (WoS)
_version_ 1809678795279433728